IR信息Denka Reveals "Denka Value-Up", a New Management Plan to Be Implemented from Fiscal 2018 to Fiscal 2022 with the Aim of Recreating Itself as a Specialty-Fusion Company
IR信息FY2017 First Half Summary of Consolidated Financial Results
IR信息FY2017 First Half Summary of Consolidated Financial Statements
IR信息FY2017 First Quarter Summary of Consolidated Financial Results
IR信息FY2017 First Quarter Summary of Consolidated Financial Statements
CSR信息Report on Third-Party Verification of Denka's GHG Emissions Data
CSR信息The Denka Group's Materiality Issues
IR信息The Denka Group Donates Ebola Virus Rapid Diagnostic Test Kits to the Democratic Republic of the Congo
IR信息FY2016 Summary of Consolidated Financial Results
IR信息FY2016 Summary of Consolidated Financial Statements
信息Progress in Obtaining U.S. FDA Approval for a Diagnostic Reagent for the Measurement of Heart Disease Risk Marker sd LDL-C and in the Denka Group’s Key Life Innovation Business
信息Notice of establishment New Company, Denka-KEW Genomics
信息Price revision for Denka Poval (Denka PVA)
信息Notice regarding the Construction of a New Hydroelectric Power Plant to Be Operated by Kurobegawa Electric Power
信息Opening Ceremony for Denka Life Innovation Research
IR信息Notice regarding Changes in Representative Directors at Denka Seiken
IR信息Notice regarding Changes in Representative Directors and Other Directors as well as Executive Officers
IR信息FY2016 Third Quarter Summary of Consolidated Financial Results
IR信息FY2016 Third Quarter Summary of Consolidated Financial Statements
信息新年致辞
本网站使用Cookie 以确保您舒适地浏览。继续浏览本网站,即表示您同意Cookie的使用。